US Cell Surface Markers Hospitals Commercial Labs Ambulatory Care Centers Physician Offices-Emerging Opportunities for Instrument and Reagent Suppliers-Competitive Strategies Country Volume & Sales Segment Forecasts

US Cell Surface Markers Hospitals Commercial Labs Ambulatory Care Centers Physician Offices-Emerging Opportunities for Instrument and Reagent Supplier

Category : Diagnostic and Biotech
Sub Category : Diagnostic Testing
July  2016  Pages : 115



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.

This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, including clinical significance and current laboratory practice, as well as five-year test volume forecasts by market segment.

image
Can't read the image ? refresh here.


Enquiry Before Buy
image
Can´t read the image ? refresh here.